(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide

C88H123N19O21S — CID 159841210

IUPAC(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
SMILESCCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)N[C@@H](CCC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)C[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C
InChIInChI=1S/C88H123N19O21S/c1-10-12-23-67-82(122)97-61(33-48(3)4)80(120)101-66(79(119)94-42-74(91)114)46-129-47-76(116)96-62(34-50-26-28-54(109)29-27-50)83(123)103(7)49(5)77(117)98-64(39-73(90)113)86(126)106-32-18-25-69(106)87(127)102(6)44-75(115)95-60(30-31-72(89)112)85(125)107-43-55(110)38-70(107)71(111)37-51(35-52-40-92-58-21-16-14-19-56(52)58)78(118)100-65(45-108)81(121)99-63(36-53-41-93-59-22-17-15-20-57(53)59)84(124)105(9)68(24-13-11-2)88(128)104(67)8/h14-17,19-22,26-29,40-41,48-49,51,55,60-70,92-93,108-110H,10-13,18,23-25,30-39,42-47H2,1-9H3,(H2,89,112)(H2,90,113)(H2,91,114)(H,94,119)(H,95,115)(H,96,116)(H,97,122)(H,98,117)(H,99,121)(H,100,118)(H,101,120)/t49-,51+,55+,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
InChIKeyNORUANVCEFDPEC-LJTLLNHWSA-N
MW1815.13 g/mol
LogP-1.83
Rot. Bonds23

About (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide

(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide (PubChem CID 159841210) has the molecular formula C88H123N19O21S and a molecular weight of 1815.13 g/mol. Its IUPAC name is (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide.

Molecular Properties

Compound Name(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
PubChem CID159841210
Molecular FormulaC88H123N19O21S
Molecular Weight1815.13 g/mol
Exact Mass1813.89
IUPAC Name(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
SMILESCCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)N[C@@H](CCC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)C[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C
InChIInChI=1S/C88H123N19O21S/c1-10-12-23-67-82(122)97-61(33-48(3)4)80(120)101-66(79(119)94-42-74(91)114)46-129-47-76(116)96-62(34-50-26-28-54(109)29-27-50)83(123)103(7)49(5)77(117)98-64(39-73(90)113)86(126)106-32-18-25-69(106)87(127)102(6)44-75(115)95-60(30-31-72(89)112)85(125)107-43-55(110)38-70(107)71(111)37-51(35-52-40-92-58-21-16-14-19-56(52)58)78(118)100-65(45-108)81(121)99-63(36-53-41-93-59-22-17-15-20-57(53)59)84(124)105(9)68(24-13-11-2)88(128)104(67)8/h14-17,19-22,26-29,40-41,48-49,51,55,60-70,92-93,108-110H,10-13,18,23-25,30-39,42-47H2,1-9H3,(H2,89,112)(H2,90,113)(H2,91,114)(H,94,119)(H,95,115)(H,96,116)(H,97,122)(H,98,117)(H,99,121)(H,100,118)(H,101,120)/t49-,51+,55+,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
InChIKeyNORUANVCEFDPEC-LJTLLNHWSA-N
XLogP-1.83
TPSA593.27 Ų
H-Bond Donors16
H-Bond Acceptors22
Rotatable Bonds23
Heavy Atoms129
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001815.13
LogP ≤ 5-1.83
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1022

Analyze (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The IUPAC name of (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide (CID 159841210) is (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide.
What is the SMILES notation for (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The canonical SMILES for (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide is CCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)N[C@@H](CCC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)C[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C.
What is the InChIKey of (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The InChIKey is NORUANVCEFDPEC-LJTLLNHWSA-N. The full InChI is InChI=1S/C88H123N19O21S/c1-10-12-23-67-82(122)97-61(33-48(3)4)80(120)101-66(79(119)94-42-74(91)114)46-129-47-76(116)96-62(34-50-26-28-54(109)29-27-50)83(123)103(7)49(5)77(117)98-64(39-73(90)113)86(126)106-32-18-25-69(106)87(127)102(6)44-75(115)95-60(30-31-72(89)112)85(125)107-43-55(110)38-70(107)71(111)37-51(35-52-40-92-58-21-16-14-19-56(52)58)78(118)100-65(45-108)81(121)99-63(36-53-41-93-59-22-17-15-20-57(53)59)84(124)105(9)68(24-13-11-2)88(128)104(67)8/h14-17,19-22,26-29,40-41,48-49,51,55,60-70,92-93,108-110H,10-13,18,23-25,30-39,42-47H2,1-9H3,(H2,89,112)(H2,90,113)(H2,91,114)(H,94,119)(H,95,115)(H,96,116)(H,97,122)(H,98,117)(H,99,121)(H,100,118)(H,101,120)/t49-,51+,55+,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-/m0/s1.
What are the key properties of (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
(3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide has a molecular weight of 1815.13 g/mol, XLogP of -1.83, 23 rotatable bonds, 16 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45R,48S,50R)-N,15-bis(2-amino-2-oxoethyl)-3-(3-amino-3-oxopropyl)-33,36-dibutyl-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-7,18,19,34,37-pentamethyl-30-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43-tridecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide is sourced from PubChem (CID 159841210), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).